Viewing Study NCT00353054



Ignite Creation Date: 2024-05-05 @ 4:57 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00353054
Status: COMPLETED
Last Update Posted: 2006-07-17
First Post: 2006-07-14

Brief Title: Effect of CalciumVitamin D Supplementation on Body Weight and Fat Loss
Sponsor: Laval University
Organization: Laval University

Study Overview

Official Title: A Double-Blind Randomized Placebo Controlled Parallel Group Study to Evaluate the Effect of CalciumVitamin D Supplementation Caltrate 600 D on Body Weight and Fat Loss in Overweight and Obese Individuals on a Weight-Reducing Program
Status: COMPLETED
Status Verified Date: 2002-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study was to assess the effect of calciumvitamin D supplementation Caltrate 600 D on body weight loss during a weight-reducing program
Detailed Description: The effect of a calcium supplementation on body weight loss is inconclusive and some studies have suggested that adequate calcium intake can have a favourable effect on some metabolic variables The objectives of this study were to evaluate the impact of Caltrate 600 D on body composition and various indicators of metabolic health in overweight and obese females characterised by a usual low daily calcium intake on a weight-reducing program

The main hypotheses of this study were

Caltrate 600 D increases body weight and fat mass losses of individuals on a weight-reducing program
Caltrate 600 D improves the metabolic profile of these subjects independently of variations promoted by body fat loss

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None